Bone dysplasia
10.1016/j.ando.2017.04.011 · doi-reference
Wnt signaling in bone development and disease: making stronger bone with wnts
10.1101/cshperspect.a007997 · doi-reference
Specific deletion of Axin1 leads to activation of β-catenin/BMP signaling resulting in fibular hemimelia phenotype in mice
10.7554/elife.80013 · doi-reference
Wnt/β-catenin signaling components and mechanisms in bone formation, homeostasis, and disease
10.1038/s41413-024-00342-8 · doi-reference
The scaffold protein AXIN1: gene ontology, signal network, and physiological function
10.1186/s12964-024-01482-4 · doi-reference
Exogenous growth hormone functionally alleviates glucocorticoid-induced longitudinal bone growth retardation in male rats by activating the ihh/PTHrP signaling pathway
10.1016/j.mce.2022.111571 · doi-reference
Food intake and sleep disorders in children and adolescents with obesity
10.3390/nu15224736 · doi-reference
Sleep disturbances and atopic dermatitis: relationships, methods for assessment, and therapies
10.1016/j.jaip.2020.12.007 · doi-reference
Recent research on the growth plate: impact of inflammatory cytokines on longitudinal bone growth
10.1530/jme-14-0006 · doi-reference
Molecular mechanisms of atopic dermatitis pathogenesis
10.3390/ijms22084130 · doi-reference
Persistent eczema leads to both impaired growth and food allergy: JECS birth cohort
10.1371/journal.pone.0260447 · doi-reference
Association between atopic dermatitis and height, body mass index, and weight in children
10.1001/jamadermatol.2021.4529 · doi-reference
FinnGen provides genetic insights from a well-phenotyped isolated population
10.1038/s41586-022-05473-8 · doi-reference
Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets
10.1038/s41590-023-01588-w · doi-reference
Whole-Genome Sequencing Consortium. Whole-genome sequencing of 490,640 UK Biobank participants
10.1038/s41586-025-09272-9 · doi-reference
Uniting biobank resources reveals novel genetic pathways modulating susceptibility for atopic dermatitis
10.1016/j.jaci.2021.07.043 · doi-reference
Genetic architectures of childhood- and adult-onset asthma are partly distinct
10.1016/j.ajhg.2019.02.022 · doi-reference
Diversity and scale: genetic architecture of 2068 traits in the VA Million Veteran Program
10.1126/science.adj1182 · doi-reference
A novel diagnostic predictive model for idiopathic short stature in children
10.3389/fendo.2021.721812 · doi-reference
Growth and puberty in children with juvenile idiopathic arthritis
10.1186/s12969-021-00521-5 · doi-reference
The NLRP3 inflammasome in allergic diseases: mechanisms and therapeutic implications
10.1007/s10238-024-01492-z · doi-reference
Glucocorticoid induced bone disorders in children: research progress in treatment mechanisms
10.3389/fendo.2023.1119427 · doi-reference
The association between atopic dermatitis and linear growth in children- a systematic review
10.1007/s00431-024-05804-z · doi-reference
Changes of GH-IGFs and its relationship with growth retardation in children with bronchial asthma
10.1016/j.clinsp.2024.100385 · doi-reference
The impact of asthma and its treatment on growth: an evidence-based review
10.1016/j.jped.2018.10.005 · doi-reference
Delay of growth and development in children with bronchial asthma, atopic dermatitis and allergic rhinitis
10.1055/s-2002-23486 · doi-reference
Economic impact of allergic diseases and asthma-the HEAD Pan-European Registry
10.1111/all.16596 · doi-reference
Global, regional, and national epidemiology of allergic diseases in children from 1990 to 2021: findings from the Global Burden of Disease Study 2021
10.1186/s12890-025-03518-y · doi-reference
GBD 2019 Allergic Disorders Collaborators, et al. Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019
10.1111/all.15807 · doi-reference
